Last 12 months
Inside the activity.
0 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 14, 2025 Filed Jan 16, 2025 21:13 UTC |
Sherman Jeffrey ScottChief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 59,382 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-25-000020 · wk-form4_1737062006.xml · derivative · entry 2 Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,382 Underlying: Common Stock · 59,382 shares Expires not disclosed F1 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 21:12 UTC |
Harris MelodyChf Ops Off, Pres, Informatics
|
GrantRestricted Stock Unit · Derivative | 59,382 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-25-000018 · wk-form4_1737061934.xml · derivative · entry 2 Harris Melody · CIK 0001880847 · Chf Ops Off, Pres, Informatics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,382 Underlying: Common Stock · 59,382 shares Expires not disclosed F1 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 21:11 UTC |
Olivo Alicia CEVP, GC & Business Development
|
GrantRestricted Stock Unit · Derivative | 59,382 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-25-000016 · wk-form4_1737061860.xml · derivative · entry 2 Olivo Alicia C · CIK 0001951869 · EVP, GC & Business Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,382 Underlying: Common Stock · 59,382 shares Expires not disclosed F2 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 21:07 UTC |
Stone WarrenChief Commerical Officer
|
GrantRestricted Stock Unit · Derivative | 59,382 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-25-000013 · wk-form4_1737061657.xml · derivative · entry 2 Stone Warren · CIK 0001955295 · Chief Commerical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,382 Underlying: Common Stock · 59,382 shares Expires not disclosed F1 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:11 UTC |
Harris MelodyChf Ops Off, Pres, Informatics
|
Tax withholdingCommon Stock | 7,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-25-000002 · wk-form4_1735938679.xml · nonDerivative · entry 1 Harris Melody · CIK 0001880847 · Chf Ops Off, Pres, Informatics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,820 F1 · shares: Shares surrendered to NeoGenomics, Inc. for retirement to satisfy the tax obligations in connection with the January 1, 2025 vesting of restricted stock. F2 · balance_after: This balance includes 1,589 shares that were acquired pursuant to NeoGenomics' Employee Stock Purchase Plan (ESPP) since the date of the reporting person's last filing. The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| December 07, 2024 Filed Dec 10, 2024 21:09 UTC |
Sherman Jeffrey ScottChief Financial Officer
|
Tax withholdingCommon Stock | 11,746 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000172 · wk-form4_1733864943.xml · nonDerivative · entry 1 Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,754 F1 · shares: Shares surrendered to NeoGenomics, Inc. for retirement to satisfy the tax obligations in connection with the December 7, 2024 vesting of restricted stock. Read SEC document |
| December 01, 2024 Filed Dec 4, 2024 02:30 UTC |
Stone WarrenChief Commerical Officer
|
Tax withholdingCommon Stock | 6,224 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000167 · wk-form4_1733279420.xml · nonDerivative · entry 1 Stone Warren · CIK 0001955295 · Chief Commerical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,822 F1 · shares: Shares surrendered to NeoGenomics, Inc. for retirement to satisfy the tax obligations in connection with the December 1, 2024 vesting of restricted stock. F2 · balance_after: On May 14, 2024, the reporting person filed a Form 4 which inadvertently reported the number of shares of common stock received upon the vesting of certain of his RSUs twice. In fact, as reported on this Form 4, the reporting person directly owned 91,046 shares of common stock after the vesting of 9,612 RSUs and reported withholding. Column 5 of Table I on this Form 4 now includes the correct number of shares received upon such May 14, 2024 vesting. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 22:43 UTC |
Olivo Alicia CGeneral Counsel
|
SaleCommon Stock | 5,175 | $15.36 | $79,475.06 |
DisclosureSEC source: 0001077183-24-000162 · wk-form4_1732056189.xml · nonDerivative · entry 1 Olivo Alicia C · CIK 0001951869 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,129 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: This balance includes 157 shares that were acquired pursuant to NeoGenomics' Employee Stock Purchase Plan (ESPP) since the date of the reporting person's last filing. The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:11 UTC |
Williams FeliciaDirector
|
GrantRestricted Stock Unit · Derivative | 7,160 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000159 · wk-form4_1730841106.xml · derivative · entry 2 Williams Felicia · CIK 0001675737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,160 Underlying: Common Stock · 7,160 shares Expires not disclosed F1 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:11 UTC |
Williams FeliciaDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,430 | $0.00 Strike: $13.59 | $0.00 |
DisclosureSEC source: 0001077183-24-000159 · wk-form4_1730841106.xml · derivative · entry 1 Williams Felicia · CIK 0001675737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,430 Underlying: Common Stock · 5,430 shares Expires 2034-06-01 Read SEC document |
| September 01, 2024 Filed Sep 4, 2024 20:08 UTC |
Olivo Alicia CGeneral Counsel
|
Tax withholdingCommon Stock | 1,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000146 · wk-form4_1725480484.xml · nonDerivative · entry 1 Olivo Alicia C · CIK 0001951869 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,147 F1 · shares: Shares surrendered to NeoGenomics, Inc. for retirement to satisfy the tax obligations in connection with the September 1, 2024 vesting of restricted stock. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 20:19 UTC |
Smith Christopher MChief Executive Officer
|
Tax withholdingCommon Stock | 33,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000143 · wk-form4_1724098745.xml · nonDerivative · entry 1 Smith Christopher M · CIK 0001436707 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 646,302 F1 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the August 15, 2024 vesting of restricted stock. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 20:17 UTC |
Olivo Alicia CGeneral Counsel
|
SaleCommon Stock | 1,040 | $16.05 | $16,695.43 |
DisclosureSEC source: 0001077183-24-000141 · wk-form4_1724098641.xml · nonDerivative · entry 1 Olivo Alicia C · CIK 0001951869 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,813 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: This balance includes 125 shares that were acquired pursuant to NeoGenomics' Employee Stock Purchase Plan (ESPP) since the date of the reporting person's last filing. The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| August 10, 2024 Filed Aug 13, 2024 20:40 UTC |
Zook Anthony P.Director
|
Exercise / conversionRestricted Stock Unit · Derivative | 11,336 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000137 · wk-form4_1723581604.xml · derivative · entry 2 Zook Anthony P. · CIK 0001582393 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,336 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| August 10, 2024 Filed Aug 13, 2024 20:40 UTC |
Zook Anthony P.Director
|
Exercise / conversionCommon Stock | 11,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000137 · wk-form4_1723581604.xml · nonDerivative · entry 1 Zook Anthony P. · CIK 0001582393 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,336 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| August 10, 2024 Filed Aug 13, 2024 20:37 UTC |
TETRAULT LYNN A.Director
|
Exercise / conversionRestricted Stock Unit · Derivative | 11,336 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000135 · wk-form4_1723581438.xml · derivative · entry 2 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,336 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| August 10, 2024 Filed Aug 13, 2024 20:37 UTC |
TETRAULT LYNN A.Director
|
Exercise / conversionCommon Stock | 11,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000135 · wk-form4_1723581438.xml · nonDerivative · entry 1 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| August 10, 2024 Filed Aug 13, 2024 20:34 UTC |
Perez David BrianDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 11,336 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000133 · wk-form4_1723581290.xml · derivative · entry 2 Perez David Brian · CIK 0001765355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,336 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| August 10, 2024 Filed Aug 13, 2024 20:34 UTC |
Perez David BrianDirector
|
Exercise / conversionCommon Stock | 11,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000133 · wk-form4_1723581290.xml · nonDerivative · entry 1 Perez David Brian · CIK 0001765355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| August 10, 2024 Filed Aug 13, 2024 20:32 UTC |
Kelly Michael AaronDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 11,336 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000131 · wk-form4_1723581122.xml · derivative · entry 2 Kelly Michael Aaron · CIK 0001769668 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,336 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| August 10, 2024 Filed Aug 13, 2024 20:32 UTC |
Kelly Michael AaronDirector
|
Exercise / conversionCommon Stock | 11,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000131 · wk-form4_1723581122.xml · nonDerivative · entry 1 Kelly Michael Aaron · CIK 0001769668 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| August 10, 2024 Filed Aug 13, 2024 20:27 UTC |
KANOVSKY STEPHEN MDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 11,336 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000129 · wk-form4_1723580855.xml · derivative · entry 2 KANOVSKY STEPHEN M · CIK 0001713090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,336 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| August 10, 2024 Filed Aug 13, 2024 20:27 UTC |
KANOVSKY STEPHEN MDirector
|
Exercise / conversionCommon Stock | 11,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000129 · wk-form4_1723580855.xml · nonDerivative · entry 1 KANOVSKY STEPHEN M · CIK 0001713090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,090 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| August 10, 2024 Filed Aug 13, 2024 20:24 UTC |
HANNAH ALISON L.Director
|
Exercise / conversionRestricted Stock Unit · Derivative | 11,336 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000127 · wk-form4_1723580646.xml · derivative · entry 2 HANNAH ALISON L. · CIK 0001645600 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,336 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| August 10, 2024 Filed Aug 13, 2024 20:24 UTC |
HANNAH ALISON L.Director
|
Exercise / conversionCommon Stock | 11,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000127 · wk-form4_1723580646.xml · nonDerivative · entry 1 HANNAH ALISON L. · CIK 0001645600 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| August 10, 2024 Filed Aug 13, 2024 20:21 UTC |
Gunn NeilDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 11,336 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000124 · wk-form4_1723580483.xml · derivative · entry 2 Gunn Neil · CIK 0001984436 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,336 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| August 10, 2024 Filed Aug 13, 2024 20:21 UTC |
Gunn NeilDirector
|
Exercise / conversionCommon Stock | 11,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000124 · wk-form4_1723580483.xml · nonDerivative · entry 1 Gunn Neil · CIK 0001984436 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,336 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| August 10, 2024 Filed Aug 13, 2024 20:17 UTC |
Floegel ElizabethDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 11,336 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000122 · wk-form4_1723580228.xml · derivative · entry 2 Floegel Elizabeth · CIK 0001984128 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,336 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| August 10, 2024 Filed Aug 13, 2024 20:17 UTC |
Floegel ElizabethDirector
|
Exercise / conversionCommon Stock | 11,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000122 · wk-form4_1723580228.xml · nonDerivative · entry 1 Floegel Elizabeth · CIK 0001984128 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,336 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 20:07 UTC |
Olivo Alicia CGeneral Counsel
|
Tax withholdingCommon Stock | 14 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000112 · wk-form4_1722888430.xml · nonDerivative · entry 1 Olivo Alicia C · CIK 0001951869 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,853 F1 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the August 1, 2024 vesting of restricted stock. F2 · balance_after: This balance includes 378 shares that were acquired pursuant to NeoGenomics' Employee Stock Purchase Plan (ESPP) since the date of the reporting person's last filing. The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:11 UTC |
Zook Anthony P.Director
|
GrantRestricted Stock Unit · Derivative | 12,254 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000097 · wk-form4_1717531862.xml · derivative · entry 4 Zook Anthony P. · CIK 0001582393 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,254 Underlying: Common Stock · 12,254 shares Expires not disclosed F1 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:11 UTC |
Zook Anthony P.Director
|
GrantStock Option (Right to Buy) · Derivative | 8,672 | $0.00 Strike: $13.71 | $0.00 |
DisclosureSEC source: 0001077183-24-000097 · wk-form4_1717531862.xml · derivative · entry 3 Zook Anthony P. · CIK 0001582393 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,672 Underlying: Common Stock · 8,672 shares Expires 2034-06-01 Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:10 UTC |
TETRAULT LYNN A.Director
|
GrantRestricted Stock Unit · Derivative | 12,254 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000096 · wk-form4_1717531825.xml · derivative · entry 10 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,254 Underlying: Common Stock · 12,254 shares Expires not disclosed F1 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:10 UTC |
TETRAULT LYNN A.Director
|
GrantStock Option (Right to Buy) · Derivative | 8,672 | $0.00 Strike: $13.71 | $0.00 |
DisclosureSEC source: 0001077183-24-000096 · wk-form4_1717531825.xml · derivative · entry 9 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,672 Underlying: Common Stock · 8,672 shares Expires 2034-06-01 Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:09 UTC |
Perez David BrianDirector
|
GrantRestricted Stock Unit · Derivative | 12,254 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000095 · wk-form4_1717531787.xml · derivative · entry 6 Perez David Brian · CIK 0001765355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,254 Underlying: Common Stock · 12,254 shares Expires not disclosed F1 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:09 UTC |
Perez David BrianDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,672 | $0.00 Strike: $13.71 | $0.00 |
DisclosureSEC source: 0001077183-24-000095 · wk-form4_1717531787.xml · derivative · entry 5 Perez David Brian · CIK 0001765355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,672 Underlying: Common Stock · 8,672 shares Expires 2034-06-01 Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:08 UTC |
KANOVSKY STEPHEN MDirector
|
GrantRestricted Stock Unit · Derivative | 12,254 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000093 · wk-form4_1717531712.xml · derivative · entry 9 KANOVSKY STEPHEN M · CIK 0001713090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,254 Underlying: Common Stock · 12,254 shares Expires not disclosed F1 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:08 UTC |
KANOVSKY STEPHEN MDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,672 | $0.00 Strike: $13.71 | $0.00 |
DisclosureSEC source: 0001077183-24-000093 · wk-form4_1717531712.xml · derivative · entry 8 KANOVSKY STEPHEN M · CIK 0001713090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,672 Underlying: Common Stock · 8,672 shares Expires 2034-06-01 Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:09 UTC |
Kelly Michael AaronDirector
|
GrantRestricted Stock Unit · Derivative | 12,254 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000094 · wk-form4_1717531749.xml · derivative · entry 8 Kelly Michael Aaron · CIK 0001769668 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,254 Underlying: Common Stock · 12,254 shares Expires not disclosed F1 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:09 UTC |
Kelly Michael AaronDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,672 | $0.00 Strike: $13.71 | $0.00 |
DisclosureSEC source: 0001077183-24-000094 · wk-form4_1717531749.xml · derivative · entry 7 Kelly Michael Aaron · CIK 0001769668 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,672 Underlying: Common Stock · 8,672 shares Expires 2034-06-01 Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:07 UTC |
HANNAH ALISON L.Director
|
GrantRestricted Stock Unit · Derivative | 12,254 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000092 · wk-form4_1717531670.xml · derivative · entry 10 HANNAH ALISON L. · CIK 0001645600 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,254 Underlying: Common Stock · 12,254 shares Expires not disclosed F1 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:07 UTC |
HANNAH ALISON L.Director
|
GrantStock Option (Right to Buy) · Derivative | 8,672 | $0.00 Strike: $13.71 | $0.00 |
DisclosureSEC source: 0001077183-24-000092 · wk-form4_1717531670.xml · derivative · entry 9 HANNAH ALISON L. · CIK 0001645600 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,672 Underlying: Common Stock · 8,672 shares Expires 2034-06-01 Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:07 UTC |
Gunn NeilDirector
|
GrantRestricted Stock Unit · Derivative | 12,254 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000091 · wk-form4_1717531627.xml · derivative · entry 4 Gunn Neil · CIK 0001984436 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,254 Underlying: Common Stock · 12,254 shares Expires not disclosed F1 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:07 UTC |
Gunn NeilDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,672 | $0.00 Strike: $13.71 | $0.00 |
DisclosureSEC source: 0001077183-24-000091 · wk-form4_1717531627.xml · derivative · entry 3 Gunn Neil · CIK 0001984436 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,672 Underlying: Common Stock · 8,672 shares Expires 2034-06-01 Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:06 UTC |
Floegel ElizabethDirector
|
GrantRestricted Stock Unit · Derivative | 12,254 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000090 · wk-form4_1717531582.xml · derivative · entry 4 Floegel Elizabeth · CIK 0001984128 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,254 Underlying: Common Stock · 12,254 shares Expires not disclosed F1 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:06 UTC |
Floegel ElizabethDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,672 | $0.00 Strike: $13.71 | $0.00 |
DisclosureSEC source: 0001077183-24-000090 · wk-form4_1717531582.xml · derivative · entry 3 Floegel Elizabeth · CIK 0001984128 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,672 Underlying: Common Stock · 8,672 shares Expires 2034-06-01 Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:07 UTC |
Olivo Alicia CGeneral Counsel
|
SaleCommon Stock | 1,049 | $15.74 | $16,511.26 |
DisclosureSEC source: 0001077183-24-000079 · wk-form4_1715976399.xml · nonDerivative · entry 1 Olivo Alicia C · CIK 0001951869 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,867 Read SEC document |
| May 11, 2024 Filed May 15, 2024 01:39 UTC |
Smith Christopher MChief Executive Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 48,063 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000075 · wk-form4_1715737144.xml · derivative · entry 4 Smith Christopher M · CIK 0001436707 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,127 Underlying: Common Stock · 48,063 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On May 11, 2023, Mr. Smith was granted 144,190 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date. F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| May 11, 2024 Filed May 15, 2024 01:39 UTC |
Smith Christopher MChief Executive Officer
|
Exercise / conversionCommon Stock | 48,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-24-000075 · wk-form4_1715737144.xml · nonDerivative · entry 3 Smith Christopher M · CIK 0001436707 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 679,432 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2024 Filed May 15, 2024 01:39 UTC |
Smith Christopher MChief Executive Officer
|
Tax withholdingCommon Stock | 18,913 | $14.86 | $281,047.18 |
DisclosureSEC source: 0001077183-24-000075 · wk-form4_1715737144.xml · nonDerivative · entry 2 Smith Christopher M · CIK 0001436707 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 631,369 F2 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.